Search
Returning search results with filters:
Remove filter for
Audience: General public
Remove filter for
Issue: Health products
Remove filter for
Type: Recall
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 144 items.
Affected lot(s) may contain the presence of Burkholderia contamination.
RecallHealth product recall | 2023-06-02
Affected lots are incorrectly labelled for use in the subpopulation that is less than 4 years of age.
RecallHealth product recall | 2023-06-01
Affected lot may contain heavy metal (arsenic) above the acceptable limit.
RecallHealth product recall | 2023-05-31
Presence of Sorafenib in affected lots.
RecallHealth product recall | 2023-05-31
Product sold without market authorization (DIN) in Canada.
RecallHealth product recall | 2023-05-30
Affected lot may contain the presence of particles.
RecallHealth product recall | 2023-05-15
An impurity is out of specification in the affected lot.
RecallHealth product recall | 2023-05-12
The Anti-Factor Ila potency is out of specification in the affected lot.
RecallHealth product recall | 2023-05-11
Auto-injectors may be malfunctioning in affected lots.
RecallHealth product recall | 2023-05-08
Affected lot is missing risk statements on the outer label; Affected lot is labelled with claims that are not compliant with its terms of market authorization; Regulated party does not hold a site licence for sale of the product in Canada.
RecallHealth product recall | 2023-05-05
Solution bags may be leaking in affected lots.
RecallHealth product recall | 2023-05-05
Affected lots may be missing the DIN and Canadian contact information on the outer label.
RecallHealth product recall | 2023-05-05
The total bacterial count is out of specification in the affected lots.
RecallHealth product recall | 2023-05-02
Unauthorized health products for use in the pediatric subpopulation.
RecallHealth product recall | 2023-04-27
Product sold without market authorization (DIN) in Canada. Affected lot contains undeclared Dehydrolatanoprost, a prostaglandin analogue. Prostaglandin analogues are listed in the prescription drug list
RecallHealth product recall | 2023-04-27